Moody’s: J&J faces ‘litigation exposure’ from talc lawsuits, proposed opioid settlement

Johnson & Johnson’s litigation risks are weighing on its credit profile, according to Moody’s Investors Service, citing the news this week that the Supreme Court denied the company’s appeal regarding a talc lawsuit and ordered it to pay $2.5 billion to 20 plaintiffs. The payment includes the original $2.1 settlement, plus interest. J&J’s shares were down 0.4% in premarket trading on Thursday. The credit ratings agency on Wednesday cited ongoing “litigation exposure” for Johnson & Johnson, including the Supreme Court decision this week, an increasing number of talc lawsuits in different states, and a proposed $5 billion settlement framework related to opioid lawsuits. The talc lawsuits allege that J&J’s Baby Powder, which includes talcum powder, caused ovarian cancer in some women who used this product. As of April 4, there were at least 28,900 plaintiffs suing J&J over talc, according to an April 4 financial filing. J&J’s stock is up 5.6% so far this year, while the broader S&P 500 is up 12.0%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.